ArticleCurrent issues in molecular biology2023

NEAT1-SOD2 Axis Confers Sorafenib and Lenvatinib Resistance by Activating AKT in Liver Cancer Cell Lines.

Hiroyuki Tsuchiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.